Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-19T08:09:35.103Z Has data issue: false hasContentIssue false

Possible Antipsychotic Effect of Fluvoxamine

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

1.Stahl, SM. Antidepressant treatment of psychotic major depression: potential role of the σ receptor. CNS Spectr. 2005;10:519523.CrossRefGoogle ScholarPubMed
2.Levkovitz, Y, Bloch, Y, Kaplan, D, Diskin, A, Abramovitchi, I. Fluvoxamine for psychosis in Alzheimer's disease. J Nerv Ment Dis. 2001;189:126129.Google Scholar
1.Stahl, SM. Antidepressant treatment of major depression: potential role of the σ receptor. CNS Spectr 2005;10:319323.Google Scholar
2.Stahl, SM. Not so selective serotonin reuptake inhibitors. J Clin Psychiatry. 1998;59:343344.Google ScholarPubMed
3.Stahl, SM. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. J Clin Psychiatry. 1998;59:642643.CrossRefGoogle Scholar
4.Stahl, SM. Selectivity of SSRIs: individualizing patient care through rational treatment choices. Int J Psy Clin Prac. 2004;8(suppl 1):310.CrossRefGoogle ScholarPubMed
5.Stahl, SM. Let them eat generics: can one atypical antipsychotic substitute for another? PsychEd Up. 2005;1:67.Google Scholar
6.Stahl, SM, Shayegan, DK. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry. 2003;64(suppl 19):612.Google ScholarPubMed
7.Shayegan, DK, Stahl, SM. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS Spectr. 2004;9(suppl 11):614.CrossRefGoogle ScholarPubMed